Outlook Therapeutics, Inc. | Business Contracts

Amended and Restated Investor Rights Agreement, dated April 21, 2022, by and between Outlook Therapeutics, Inc. and GMS Ventures and Investments (Filed With SEC on April 22, 2022)

Executive Employment Agreement by and between Jeff Evanson and Outlook Therapeutics, Inc, dated December 21, 2021 (Filed With SEC on December 23, 2021)

At The Market Offering Agreement between the Company and H.C. Wainwright & Co. dated March 26, 2021 (Filed With SEC on March 26, 2021)

Lease Termination Agreement dated, May 6, 2020 between the Registrant and Cedar Brook Corporate Center, LP (Filed With SEC on August 14, 2020)

Termination Agreement and Mutual Release between the Company and MTTR LLC, dated as of January 27, 2020 (Filed With SEC on January 31, 2020)

Executive Employment Agreement by and between Terry Dagnon and Outlook Therapeutics, Inc, dated December 21, 2021 (Filed With SEC on December 23, 2021)

Form of Underwriter Warrant (Filed With SEC on November 29, 2021)

Amended and Restated Underwriting Agreement, dated November 23, 2021, by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on November 29, 2021)

Note Amendment dated November 16, 2021 (Filed With SEC on November 16, 2021)

Promissory Note dated November 16, 2021 (Filed With SEC on November 16, 2021)

Note Purchase Agreement between the Company and Streeterville Capital, LLC, dated as of November 16, 2021 (Filed With SEC on November 16, 2021)

Amendment No. 1 to Consulting Agreement between the Company and The Dagnon Group LLC (Dagnon) dated as of November 8, 2021 (Filed With SEC on November 12, 2021)

Amendment No.1 to Consulting Agreement between the Company and Scott Three Consulting, LLC (Evanson) dated as of November 8, 2021 (Filed With SEC on November 12, 2021)

Executive Employment Agreement by and between Lawrence Kenyon and Outlook Therapeutics, Inc, dated July 27, 2021 (Filed With SEC on July 30, 2021)

Executive Employment Agreement by and between C. Russell Trenary III and Outlook Therapeutics, Inc, dated July 6, 2021 (Filed With SEC on July 9, 2021)

Securities Purchase Agreement, dated February 9, 2021, by and between the Company and GMS Ventures and Investments (Filed With SEC on February 11, 2021)

Securities Purchase Agreement, dated January 28, 2021, by and between the Company and Syntone Ventures LLC (Filed With SEC on February 2, 2021)

Form of Underwriter Warrants (Filed With SEC on February 2, 2021)

Underwriting Agreement, dated January 28, 2021, by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on February 2, 2021)

Description of Registrants securities (Filed With SEC on December 23, 2020)

Promissory Note dated November 4, 2020 (Filed With SEC on November 6, 2020)

Note Purchase Agreement between the Company and Streeterville Capital, LLC, dated as of November 4, 2020 (Filed With SEC on November 6, 2020)

Form of Placement Agent Warrant (Filed With SEC on June 23, 2020)

Engagement Letter, dated June 2, 2020, by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on June 23, 2020)

Securities Purchase Agreement, dated June 22, 2020, by and between the Company and Syntone Ventures LLC (Filed With SEC on June 23, 2020)

Form of Securities Purchase Agreement, dated June 22, 2020, by and among the Company and the purchasers named therein (Filed With SEC on June 23, 2020)

Stock Purchase Agreement, dated May 22, 2020, by and between the Company and Syntone Ventures LLC (Filed With SEC on May 28, 2020)

Fourth Amendment to Investor Rights Agreement dated September 11, 2017 by and between the Company and BioLexis Pte. Ltd. (formerly GMS Tenshi Holdings Pte. Limited), by and... (Filed With SEC on February 24, 2020)

Engagement letter dated December 10, 2019 by and between the Company and H.C. Wainwright & Co. LLC (Filed With SEC on February 24, 2020)

Securities Purchase Agreement by and between the Company and GMS Ventures and Investments dated February 24, 2020 (Filed With SEC on February 24, 2020)

Form of Securities Purchase Agreement, dated February 24, 2020, by and among the Company and the purchasers named therein (Filed With SEC on February 24, 2020)

Form of Placement Agent Warrant (Filed With SEC on February 24, 2020)

Form of GMS Stock Purchase Warrant (Filed With SEC on February 24, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on February 24, 2020)

Consulting Agreement between the Company and The Dagnon Group LLC (Dagnon), dated as of January 27 2020 (Filed With SEC on January 31, 2020)

Amendment to Warrants to Purchase Common Stock between the Company and BioLexis Pte. Ltd., dated as of January 27, 2020 (Filed With SEC on January 31, 2020)

Agreement to Amend Series A-1 Convertible Preferred between the Company and BioLexis Pte. Ltd., dated as of January 27, 2020 (Filed With SEC on January 31, 2020)

Global Amendment, dated as of January 29, 2020 (Filed With SEC on January 31, 2020)

Consulting Agreement between the Company and Scott Three Consulting, LLC (Evanson), dated as of January 27, 2020 (Filed With SEC on January 31, 2020)

Amendment #2 dated December 23, 2019 of Warrant Agreement between the Company and American Stock Transfer & Trust Company LLC, as warrant agent, dated as of April 12, 2019, as... (Filed With SEC on December 23, 2019)

Form of Senior Secured Promissory Note (Filed With SEC on December 23, 2019)

Exchange Agreement dated December 23, 2019 (Filed With SEC on December 23, 2019)

Amendment dated March 4, 2019 of Strategic Partnership Agreement between the Registrant and MTTR LLC effective as of February 15, 2018, as amended (Filed With SEC on December 19, 2019)

Third Note Amendment dated June 28, 2019 (Filed With SEC on July 1, 2019)

Amendment #1 dated June 11, 2019 of Warrant Agreement between the Company and American Stock Transfer & Trust Company LLC, as warrant agent, dated as of April 12, 2019 (Filed With SEC on June 14, 2019)

Amendment dated June 4, 2019 of Strategic Partnership Agreement between the Company and MTTR LLC effective as of February 15, 2018, as amended (Filed With SEC on June 10, 2019)

Warrant Agreement, including form of 15-Month Warrant and form of Five-Year Warrant by and between the Registrant and American Stock Transfer & Trust Company, LLC, as Warrant... (Filed With SEC on May 15, 2019)

Separation and Release Agreement between the Registrant and Kenneth M. Bahrt, M.D., dated April 23, 2019 (Filed With SEC on April 26, 2019)

Form of Warrant Agreement including form of 15-Month Warrant and form of Five-Year Warrant (Filed With SEC on April 9, 2019)

Form of Underwriting Agreement (Filed With SEC on April 9, 2019)

Form of Underwriting Agreement (Filed With SEC on April 2, 2019)

Amendment #3 to the Warrant Agreement dated May 18, 2016, by and between Outlook Therapeutics, Inc. and American Stock Transfer & Trust Company LLC, as Warrant Agent, dated... (Filed With SEC on January 22, 2019)

Outlook Therapeutics, Inc. (52)